27.77 cr vax doses administered to pregnant women, kids; Bihar & UP
New Delhi, Nov 29 (IANS) The U-WIN digital platform has recorded the administration of about 27.77 crore vaccine doses to pregnant women, and children in India, with Bihar and Uttar Pradesh taking the lead, said Union Minister of State for Health and Family Welfare Anupriya Patel, in a written reply in the Lok Sabha on
177. 27.77 cr vax doses administered to pregnant women, kids; Bihar & UP take lead: Centre
New Delhi, Nov 29 (IANS) The U-WIN digital platform has recorded the administration of about 27.77 crore vaccine doses to pregnant women, and children in India, with Bihar and Uttar Pradesh taking the lead, said Union Minister of State for Health and Family Welfare Anupriya Patel, in a written reply in the Lok Sabha on Friday.
U-WIN is a digital platform for the digitalisation of all vaccination services provided under the Universal Immunisation Programme (UIP) to ensure the timely administration of life-saving vaccines to pregnant women and children (from birth to 16 years) against 12 vaccine-preventable diseases.
“As of November 25, 7.43 crore beneficiaries have been registered, 1.26 crore vaccination sessions have been held and 27.77 crore administered vaccine doses have been recorded on U-WIN,” Patel said.
“The increased daily usage of the platform has further created awareness and ready access to immunisation services among both citizens and frontline workers,” she added.
Bihar leads with more than 6.7 crore total doses administered, followed by Uttar Pradesh (more than 5.9 crore doses) and Madhya Pradesh (2.2 crore). Lakshadweep with 33,266 had the lowest count.
Further, Uttar Pradesh had the highest number of beneficiaries registered (more than 1.6 crore), followed by Bihar (with over 1.5 crore). Lakshadweep with 6,821 beneficiaries has the lowest count.
With the nationwide roll-out of U-WIN completed, the Health Ministry aims to annually target around 2.9 crore pregnant women and 2.6 crore infants (0-1 year).
Its key features include ‘Anytime Access’ and ‘Anywhere’ vaccination services, generation of Ayushman Bharat Health Account (ABHA) and Child ABHA, citizen module, automated SMS alerts, QR-based e-Vaccination Certificate, and offline mode for data entry by vaccinators.
The initial pilot of U-WIN was conducted across 63 districts in 35 States/UTs followed by the nationwide roll-out, the ministry said.
–IANS
rvt/uk
Odisha Govt Approves Industrial Projects worth around Rs 1.37 Lakh Crore
Next ArticlePM Modi to reach Bhubaneswar today on three-day Odisha visit
Related Articles
New AI tool to revolutionise personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

स्वास्थ्य व लाइफस्टाइलCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
